PDA

View Full Version : Reports and Research

  1. Unos
  2. Types of Liver Diseases
  3. BA in a Border Collie
  4. Differential diagnosis of infantile choledochal cyst with or without biliary atresia
  5. Pediatric Liver Transplant With Campath 1H Induction - Preliminary Report.
  6. Successful liver transplantation across the ABO incompatibility barrier in 6 cases of
  7. Long-term outcome in type I biliary atresia.
  8. The role of monocyte chemoattractant protein-1 in biliary atresia
  9. Association of serum levels of tissue inhibitors of metalloproteinase-1 with clinical
  10. Prognostic value of portal pressure at the time of Kasai operation in patients with b
  11. The model for end-stage liver disease score is useful for predicting economic outcome
  12. Liver transplantation at Red Cross War Memorial Children's Hospital.
  13. Biliary atresia with choledochal cyst: implications for classification
  14. Types of Biliary Atresia
  15. Visual loss and idiopathic intracranial hypertension in children with Alagille syndro
  16. Effect of living donor liver transplantation on outcome of children with inherited li
  17. Liver involvement in celiac disease
  18. Immunosuppressive therapy does not prevent the occurrence of immunoglobulin E-mediate
  19. Variable degree of liver involvement in siblings with PiZZ alpha-1-antitrypsin defici
  20. Decreased protein C activation in patients with fulminant hepatic failure.
  21. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized,
  22. Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysi
  23. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences
  24. Autoimmune hepatitis in children
  25. Pregnancy in biliary atresia after kasai operation complicated by portal hypertension
  26. Intrahepatic cystic lesions after hepatic portoenterostomy for biliary atresia with b
  27. Pulmonary vascular abnormalities in cirrhosis
  28. Safety of living-related liver transplantation for progressive familial intrahepatic
  29. Novel resequencing chip customized to diagnose mutations in patients with inherited s
  30. Neonatal hemochromatosis: long-term experience with favorable outcome.
  31. Whatever happened to "neonatal hepatitis"?
  32. Imaging findings in congenital hepatic fibrosis
  33. Drug insight: the role of albumin in the management of chronic liver disease.
  34. Short hepatic vein reconstruction in biliary atresia patients with absent inferior ve
  35. The Interactive Body
  36. UNOS publications
  37. NIDDK research article
  38. Significance of C4d staining in ABO-identical/compatible liver transplantation
  39. Biliary intraepithelial neoplasia: an international interobserver agreement study and
  40. Vascular complications after orthotopic liver transplantation after neoadjuvant thera
  41. Urinary tract infection in non-hospitalized patients with cirrhosis and no symptoms o
  42. Hepaticojejunostomy-Analysis of Risk Factors for Postoperative Bile Leaks and Surgica
  43. Risk factors for and management of delayed intraperitoneal hemorrhage after pancreati
  44. Duration of antimicrobial prophylaxis in patients undergoing hepatectomy: a prospecti
  45. Seasonal Incidents in biliary atresia
  46. Characterization of erythrovirus B19 genomes isolated in liver tissues from patients
  47. Telbivudine: a new option for the treatment of chronic hepatitis B.
  48. Non-alcoholic fatty liver disease and childhood obesity.
  49. Mycophenolate Mofetil in Autoimmune Hepatitis Patients Not Responsive or Intolerant t
  50. Angiographic Findings in Biliary Atresia
  51. Frequency of urinary tract infection in pediatric liver transplantation candidates
  52. Short hepatic vein reconstruction in biliary atresia patients with absent inferior ve
  53. Experience with choledochal cysts in infants
  54. Study: Liver Cancer Breakthrough Found
  55. Stem cells as a therapeutic modality in pediatric malformations
  56. Early hepatic artery thrombosis after liver transplantation: diagnosis and treatment
  57. Effect of intraoperative hyperglycemia during liver transplantation
  58. Alpha-1-Antitrypsin Deficiency: Current Concepts
  59. Liver Cancer Pill Extends Lives
  60. ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Pati
  61. British scientists grow human liver in a laboratory
  62. Vaccinations for Adult Solid-Organ Transplant Recipients Part 1
  63. Babies Receive Recommended Newborn Screening Tests
  64. Pediatrics Newborn Screening Fact Sheet
  65. Drugs and Medications that Cause Liver Disease
  66. Herbal Medications and Liver Disease
  67. Religious Views on Donation
  68. Radiofrequency (RF)-Assisted Hepatectomy May Induce Severe Postoperative Liver Damage
  69. Minimal access portoenterostomy: advantages and disadvantages of standard laparoscopi
  70. Hepatic Arterial Diameter Measured with US: Adjunct for US Diagnosis of Biliary Atres
  71. Hyaluronic acid: Additional biochemical marker in the diagnosis of biliary atresia.
  72. Early stage of biliary atresia is associated with significant changes in 8-hydroxydeo
  73. Analysis of Model for End-Stage Liver Disease (MELD) Score in a Liver Transplantation
  74. Histological recurrence of autoimmune liver diseases after living-donor liver transpl
  75. Paediatric liver transplantation in New Zealand: the first 5 years.
  76. Excerpt from Biliary Atresia